Phibro Animal Health (PAHC) Raw Materials (2013 - 2026)

Phibro Animal Health's Raw Materials history runs 14 years deep, the most recent figure standing at $191.7 million for Q1 2026.

• In Q1 2026, Raw Materials rose 27.13% year-over-year to $191.7 million; the TTM figure through Mar 2026 stood at $191.7 million (up 27.13% YoY), while the FY2025 annual figure was $162.6 million, up 123.39% from the prior year.
• Raw Materials was $191.7 million for Q1 2026 at Phibro Animal Health, up from $178.5 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $191.7 million in Q1 2026 to a low of $72.8 million in Q2 2024.
• Historically, Raw Materials has averaged $112.8 million across 5 years, with a median of $87.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Raw Materials fell 20.21% in 2023, then jumped 123.39% in 2025.
• A 5-year view of Raw Materials shows it stood at $96.6 million in 2022, then fell by 20.21% to $77.0 million in 2023, then surged by 89.35% to $145.9 million in 2024, then climbed by 22.34% to $178.5 million in 2025, then grew by 7.4% to $191.7 million in 2026.
• The last three Raw Materials figures came in at $191.7 million (Q1 2026), $178.5 million (Q4 2025), and $166.4 million (Q3 2025), per Business Quant data.